which is attributed to the formation of Ni3B phases, and heat treat- ment above 250 °C led to the formation of the Ni3B crystalline phase; • The maximum hardness was obtained for heat treatment of 4 h at 300 °C and was 40% higher than the hardness of the as-deposited coating. ...
This study explored a novel treatment method for HAE infringing on the IVC and evaluated the safety and feasibility of combined resection of the liver and the IVC. A total of 13 patients were treated with liver resection combined with IVC resection for end-stage HAE between January 2016 and ...
New hep C drugs shift treatment plansOn December 6, FDA approved Sovaldi (sofosbuvir) tablets for the treatment of chronic hepatitis C (CHC) infection as a component of a combination antiviral treatment regimen.Julie MillerHealthcare executive...
selective cytotoxicity on normal liver cells was assessed for the most potent compound. Moreover, the proapoptotic activity, cell cycle alteration and gene and protein expression changes affected by treatment of HepG2 cells with
Plant-derived medications are sought after for anticancer treatment since they are both natural and widely available. They are easily supplied orally as part of the patient's diet17,18. Furthermore, because they are naturally generated from plants, they are often more tolerated and non-toxic to...
Isolated DNA was subjected to RNAse treatment followed by phenol-chloroform extraction and ethanol precipitation. The quality of the isolated DNA was assessed by visualization following agarose gel electrophoresis and the DNA was quantified by using NanoDrop 1000 spectrophotometer. Metagenomic DNA ...
The mEHT treatment also caused a significant elevation of DNA fragmentation, nuclear shrinkage, and an increased number of apoptotic bodies. Furthermore, it caused an increase in both the amount of BAX protein and the release of cytochrome c from the mitochondria to the cytoplasm, indicating that...
C. melo has potential in the treatment of pain, inflammation, cough, dysuria, diabetes, liver diseases, and cardiovascular disorders (Ibrahim, 2010, Ibrahim, 2014). It exhibited antioxidant, antimicrobial, and anti-inflammatory activities (Ibrahim, 2010, Ibrahim, 2014, Vouldoukis et al., 2004)...
Casgevy recently became the first FDA-approved CRISPR-based gene editing technology for the treatment of Sickle Cell Disease [26]. Additionally, CRISPR-Cas9 is being evaluated for in vivo delivery using mRNA-LNP system, with treating transthyretin amyloidosis initiated in 2021 [27]. In Fig.1A, ...
ensuring more effectively treatment consequences when used along-side anti-PD-L1 therapy. In experiments with combination therapy using low-dose an-ti-PD-L1, approximately 70% of tumors completely regressed, whereas the tumor regression rates with anti-PD-L1 or NA1C monotherapy were only about 10...